Physician profile

Nicholas Namias

Surgical Critical Care · Miami, FL

NPI 1326004227

$12,848.99

in general payments reported to CMS, 2019-2025

5 companies · none reported in 2025

See the full distribution for Surgical Critical Care

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$5,000.00
Travel and Lodging$1,133.33
Food and Beverage$642.20

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Molnlycke Health Care US, LLC $6,617.19 2024 Biogel Pi Micro Indicator Underglove, Biogel Pi Indicator Underglove, Biogel Indicator System
Merck Sharp & Dohme LLC $5,000.00 2020-2021
Csl Behring $1,073.46 2022
Baxter Healthcare $143.75 2024 Floseal
Urgo Medical North America, LLC $14.59 2024 Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Nicholas Namias

$12,848.99

in general payments reported 2019-2025

Years
2020-2024
Top company
Molnlycke Health Care US, LLC

https://glasscript.com/doctor/685862/nicholas-namias

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.